Facial and ocular deposition of nebulized budesonide: Effects of face mask design

Chest

Volumn 133, Issue 2, 2008, Pages 482-488

  Harris, Keith W ^a   Smaldone, Gerald C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Deposition; High performance liquid chromatography; Nebulized budesonide

Indexed keywords

BUDESONIDE;

AEROSOL; ARTICLE; BREATHING PATTERN; DRUG DELIVERY SYSTEM; EYE; FACE; FACE MASK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NEBULIZER; PARTICLE SIZE; PHYSICAL MODEL; PRIORITY JOURNAL; TIDAL VOLUME;

EID: 39449093951     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1827     Document Type: Article

References (17)

1. Bisquerra RA, Botz GH, Nates JL. Ipratropium-bromide-induced acute anisocoria in the intensive care setting due to ill-fitting face masks. Respir Care 2005; 50:1662-1664
2. Iosson N. Images in clinical medicine: nebulizer-associated anisocoria. N Engl J Med 2006; 354:e8
3. Hall SK. Acute angle-closure glaucoma as a complication of combined beta-agonist and ipratropium bromide therapy in the emergency department. Ann Emerg Med 1994; 23:884-887
4. Brodie T, Adalat S. Unilateral fixed dilated pupil in a well child [letter]. Arch Dis Child 2006; 91:961
5. Erzinger S, Schueepp KG, Brooks-Wildhaber J, et al. Facemasks and aerosol delivery in vivo. J Aerosol Med 2007; 20(suppl 1):S78-S84
6. Ryan CA. Styrofoam cup, ipratropium bromide, and anisocoria [letter]. Clin Pediatr (Phila) 1999; 38:318
7. Woelfle J, Zielen S, Lentze MJ. Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide. J Pediatr 2000; 136:423-424
8. Mulpeter KM, Walsh JB, O'Connor M, et al. Ocular hazards of nebulized bronchodilators. Postgrad Med J 1992; 68:132-133
9. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 2001; 108:389-394
10. Morton RW, Mitchell JP. Design of facemasks for delivery of aerosol-based medication via pressurized metered dose inhaler with valved holding chamber: key issues that affect performance. J Aerosol Med 2007; 20(suppl 1):S29-S45
11. Nikander K, Berg E, Smaldone GC. Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery. J Aerosol Med 2007; 20(suppl 1):S46-S58
12. Smaldone GC, Berg E, Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 2005; 18:354-363
13. Sangwan S, Gurses BK, Smaldone GC. Facemasks and facial deposition of aerosols. Pediatr Pulmonol 2004; 37:447-452
14. Smaldone CC, Sangwan S, Shah A. Facemask design, facial deposition, and delivered dose of nebulized aerosols. J Aerosol Med 2007; 20(suppl 1):S66-S77
15. Smaldone GC, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998; 11:113-125
16. Diot P, Palmer LB, Smaldone A, et al. RhDNase I aerosol deposition and related factors in cystic fibrosis. Am J Respir Crit Care Med 1997; 156:1662-1668
17. Hess DR. The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med 2007; 20(suppl 1):S85-99